Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

NCT02998268 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Adenocarcinoma

Interventions

DRUG: Pembrolizumab
DRUG: Taxol
DRUG: Carboplatin

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]